Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Radiopharmaceuticals market. The report considers 2020-2023 historic period, 2024 as base year, and 2025-2035 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition.
Radiopharmaceuticals market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Radiopharmaceuticals market is estimated to expand at a considerable growth rate during the forecast period owing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Radiopharmaceuticals products across developed and developing countries of the world.
Key Research Highlights: Market Restraints
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Radiopharmaceuticals products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Radiopharmaceuticals market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Radiopharmaceuticals development has been the leading industry trend of Radiopharmaceuticals market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increasing spending on research and development and growing number of new product approvals.
Global Radiopharmaceuticals Market Size, 2020-2035 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2024 |
USD XX.XX Million |
| CAGR (2025 - 2035) |
XX.XX % |
| The Revenue forecast in 2035 |
USD XX.XX Million |
| Base year for estimation |
2024 |
| Historical data |
2020-2023 |
| Forecast period |
2025-2035 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2025 to 2035
|
| Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
By Radioisotope Outlook, End-User Outlook, Regional Outlook |
| By Radioisotope Outlook |
Technetium 99, Fluorine 18, Iodine 131, Lutetium 177, Yttrium 90, Gallium 67, Gallium 68, Rubidium 82, Iodine 123, Iodine 125, Indium 111, Other |
| By End-User Outlook |
Hospitals, Medical Imaging Centers, Cancer Research Institute, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer AG, Bracco Imaging, Cardinal Health, Curium Pharma, Eckert and Ziegler, Eli Lilly, General Electric, IBA Radiopharma Solutions, Jubilant Pharma, Lantheus Holdings, Mallinckrodt, Nordion (Canada) |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Bayer AG
- Bracco Imaging
- Cardinal Health
- Curium Pharma
- Eckert and Ziegler
- Eli Lilly
- General Electric
- IBA Radiopharma Solutions
- Jubilant Pharma
- Lantheus Holdings
- Mallinckrodt
- Nordion (Canada)
Radiopharmaceuticals Market, By Radioisotope
- Technetium 99
- Fluorine 18
- Iodine 131
- Lutetium 177
- Yttrium 90
- Gallium 67
- Gallium 68
- Rubidium 82
- Iodine 123
- Iodine 125
- Indium 111
- Other
Radiopharmaceuticals Market, By Type of Source
- Cyclotrons
- Nuclear Reactors
- Other
Radiopharmaceuticals Market, By Purpose Type
Radiopharmaceuticals Market, By Application
- Oncology
- Cardiology
- Gastroenterology
- Neuroendocrinology
- Neurology
- Nephrology
- Other
Radiopharmaceuticals Market, By End-User
- Hospitals
- Medical Imaging Centers
- Cancer Research Institute
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Chapter 1 Radiopharmaceuticals Market Overview
1.1 Radiopharmaceuticals Definition
1.2 Global Radiopharmaceuticals Market Size Status and Outlook (2019-2026)
1.3 Global Radiopharmaceuticals Market Size Comparison by Region (2019-2026)
1.4 Global Radiopharmaceuticals Market Size Comparison by Type (2019-2026)
1.5 Global Radiopharmaceuticals Market Size Comparison by Application (2019-2026)
1.6 Global Radiopharmaceuticals Market Size Comparison by Sales Channel (2019-2026)
1.7 Radiopharmaceuticals Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Radiopharmaceuticals Market Segment Analysis by Player
2.1 Global Radiopharmaceuticals Sales and Market Share by Player (2017-2018)
2.2 Global Radiopharmaceuticals Revenue and Market Share by Player (2017-2018)
2.3 Global Radiopharmaceuticals Average Price by Player (2017-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Radiopharmaceuticals Market Segment Analysis by Type
3.1 Global Radiopharmaceuticals Market by Type
3.1.1 Diagnostic Radioisotopes
3.1.2 Therapeutic Radioisotopes
3.2 Global Radiopharmaceuticals Sales and Market Share by Type (2014-2018)
3.3 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2018)
3.4 Global Radiopharmaceuticals Average Price by Type (2014-2018)
3.5 Leading Players of Radiopharmaceuticals by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Radiopharmaceuticals Market Segment Analysis by Application
4.1 Global Radiopharmaceuticals Market by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceuticals Sales and Market Share by Application (2014-2018)
4.3 Leading Consumers of Radiopharmaceuticals by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Radiopharmaceuticals Market Segment Analysis by Sales Channel
5.1 Global Radiopharmaceuticals Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Radiopharmaceuticals Sales and Market Share by Sales Channel (2014-2018)
5.3 Leading Distributors/Dealers of Radiopharmaceuticals by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Radiopharmaceuticals Market Segment Analysis by Region
6.1 Global Radiopharmaceuticals Market Size and CAGR by Region (2019-2026)
6.2 Global Radiopharmaceuticals Sales and Market Share by Region (2014-2018)
6.3 Global Radiopharmaceuticals Revenue and Market Share by Region (2014-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Radiopharmaceuticals Market Share by Type
6.4.3 North America Radiopharmaceuticals Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Radiopharmaceuticals Market Share by Type
6.5.3 Europe Radiopharmaceuticals Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Radiopharmaceuticals Market Share by Type
6.6.3 Asia-Pacific Radiopharmaceuticals Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Radiopharmaceuticals Market Share by Type
6.7.3 South America Radiopharmaceuticals Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Radiopharmaceuticals Market Share by Type
6.8.3 Middle East & Africa Radiopharmaceuticals Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Radiopharmaceuticals Players
7.1 Bracco Imaging
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Bayer
7.3 Mallinckrodt
7.4 Nordion
7.5 Triad Isotopes
7.6 Lantheus
7.7 IBA Group
7.8 GE Healthcare
7.9 China Isotope & Radiation
7.10 Jubilant Pharma
7.11 Eli Lilly
7.12 Advanced Accelerator Applications
7.13 SIEMENS
7.14 Dongcheng
7.15 Navidea
Chapter 8 Upstream and Downstream Analysis of Radiopharmaceuticals
8.1 Industrial Chain of Radiopharmaceuticals
8.2 Upstream of Radiopharmaceuticals
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Radiopharmaceuticals
8.3.1 Leading Distributors/Dealers of Radiopharmaceuticals
8.3.2 Leading Consumers of Radiopharmaceuticals
Chapter 9 Development Trend of Radiopharmaceuticals (2019-2026)
9.1 Global Radiopharmaceuticals Market Size (Sales and Revenue) Forecast (2019-2026)
9.2 Global Radiopharmaceuticals Market Size and CAGR Forecast by Region (2019-2026)
9.3 Global Radiopharmaceuticals Market Size and CAGR Forecast by Type (2019-2026)
9.4 Global Radiopharmaceuticals Market Size and CAGR Forecast by Application (2019-2026)
9.5 Global Radiopharmaceuticals Market Size Forecast by Sales Channel (2019-2026)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
